Medical condition
Asthma
Asthma is a medical condition tracked by NovaPharmaNews across 12 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- salmeterol (SEFFALAIR SPIROMAX) Respiratory system (R03)
- budesonide (BUDENOFALK) Alimentary tract and metabolism (A07)
- salmeterol xinafoate (AIREXAR SPIROMAX) Respiratory system (R03)
- reslizumab (CINQAERO) Respiratory system (R03)
- dupilumab (DUPIXENT) Dermatologicals (D11)
- benralizumab (FASENRA PEN) Respiratory system (R03)
- fluticasone furoate (ARNUITY ELLIPTA) Respiratory system (R03)
- mepolizumab (NUCALA) Respiratory system (R03)
- dexamethasone phosphate (DEXAMETHASONE TAW) Systemic hormonal preparations (H02)
- beclometasone (TRYDONIS) Respiratory system (R03)
- indacaterol (ONBREZ) Respiratory system (R03)
- omalizumab (OMLYCLO) Respiratory system (R03)
Latest Asthma news
AstraZeneca's BREZTRI Aerosphere Approved as First Triple Therapy for Asthma in Patients 12 and Older
AstraZeneca receives FDA approval for BREZTRI Aerosphere as the first and only triple-combination therapy for asthma maintenance treatment in patients aged 12+.
FDA Approves Inno-Med's Inhaler-Tech: Asthma Drug Delivery Innovation
Inno-Med's Inhaler-Tech has received FDA approval, marking a significant advancement in asthma drug delivery technology for improved patient outcomes.
FDA Approves AirFlow: New Inhalable Treatment for Severe Asthma
The FDA has approved AirFlow, a novel inhalable treatment for severe asthma, promising improved management and quality of life for patients.